Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Bristol-Myers Squibb
Bristol-Myers Squibb
Bristol-Myers Squibb: New Product Potential Outstanding, But Patent Cliff Looms
Seeking Alpha
Thu, 07/28/11 - 06:08 pm
pipelines
earnings
Bristol-Myers Squibb
patents
Bristol-Myers profit falls but sales jump 14 pct
Yahoo/AP
Thu, 07/28/11 - 11:13 am
earnings
Bristol-Myers Squibb
Switching Partners Provides a Big Shot in the Arm
Motley Fool
Wed, 07/27/11 - 10:54 pm
Merck
Cardiome
Astellas
Pfizer
Bristol-Myers Squibb
JNJ
Four Drug Stocks To Watch On Thursday
Investopedia
Wed, 07/27/11 - 01:21 pm
Celgene
Bristol-Myers Squibb
United Therapeutics
Sanofi
Lilly Study Imperils Alzheimer's Drugs
TheStreet.com
Wed, 07/27/11 - 12:32 pm
Eli Lilly
Pfizer
JNJ
Bristol-Myers Squibb
semagacestat
Elan
Alzheimer's disease
Earnings Preview: Bristol-Myers
Yahoo/Zacks.com
Tue, 07/26/11 - 04:34 pm
earnings
Bristol-Myers Squibb
Bristol-Myers' Acquisition Could Pay for Itself
Motley Fool
Mon, 07/25/11 - 07:37 pm
M&A
Bristol-Myers Squibb
Amira
Bristol-Myers Squibb Co. Second Quarter Earnings Sneak Peek
Yahoo/Wall St. Cheat Sheet
Mon, 07/25/11 - 11:53 am
earnings
Bristol-Myers Squibb
Key blockbuster drugs about to get generic rivals
Yahoo/AP
Mon, 07/25/11 - 09:10 am
generics
Eli Lilly
Forest Labs
Pfizer
AstraZeneca
Cephalon
Bristol-Myers Squibb
Sanofi
patents
Abbott Laboratories
Merck
Takeda
Novartis
Endo
GSK
Anti-Coagulant Blockbuster Drugs Are Here
Seeking Alpha
Mon, 07/25/11 - 09:08 am
anticlotting
blood thinners
JNJ
Pfizer
AstraZeneca
Bristol-Myers Squibb
Bayer
Xarelto
Pradaxa
Boehringer Ingelheim
Eliquis
Bristol-Myers Acquires Amira Pharmaceuticals, Scoops Up Lung Drug
Motley Fool
Sat, 07/23/11 - 03:13 pm
Amira
Bristol-Myers Squibb
pulmonary fibrosis
Drugmaker Bristol-Myers acquires Amira Pharma in deal that could be worth $475 million
Yahoo/AP
Fri, 07/22/11 - 09:33 am
M&A
Bristol-Myers Squibb
Amira
As Dapagliflozin Receives Negative Vote, What's Next for Bristol Myers?
Seeking Alpha
Thu, 07/21/11 - 10:57 am
Bristol-Myers Squibb
Dapagliflozin
Pfizer
Eli Lilly
AstraZeneca
JNJ
Yervoy
AstraZeneca Wins U.S. Approval for Blood Thinner Brilinta to Rival Plavix
Bloomberg
Wed, 07/20/11 - 06:46 pm
Plavix
blood thinners
AstraZeneca
Sanofi
Bristol-Myers Squibb
Brilinta
AAIC: High Dose of Bristol’s Avagacestat May Also Be Tied to Cognitive Problems
WSJ Online
Wed, 07/20/11 - 11:17 am
Avagacestat
Alzheimer's disease
Bristol-Myers Squibb
Bristol, AstraZeneca Rebuffed by FDA Panel on Diabetes Drug
Bloomberg
Tue, 07/19/11 - 06:11 pm
FDA
AstraZeneca
diabetes
Bristol-Myers Squibb
Dapagliflozin
Regulatory "sword of Damocles" dangles over two big AZ drugs
Fierce Biotech
Tue, 07/19/11 - 01:14 pm
AstraZeneca
FDA
Brilinta
blood thinners
Dapagliflozin
Bristol-Myers Squibb
Glaxo-Pfizer AIDS Pill May Dislodge Bristol’s, Study Suggests
Bloomberg
Tue, 07/19/11 - 12:22 pm
AIDS
HIV
GSK
Pfizer
Bristol-Myers Squibb
Dolutegravir
Sustiva
ViiV Healthcare
Immunocellular Therapeutics: An Interesting Biotech
Seeking Alpha
Tue, 07/19/11 - 12:12 pm
ImmunoCellular Therapeutics
cancer
Bristol-Myers Squibb
Dendreon
Oncothyreon
Eli Lilly: Poised to Reward Patient Investors?
Seeking Alpha
Tue, 07/19/11 - 10:15 am
Eli Lilly
investors
Abbott Laboratories
AstraZeneca
Bristol-Myers Squibb
Forest Labs
Impax
Mylan
Teva Pharmaceuticals
Watson Pharmaceuticals
Pages
« first
‹ previous
…
86
87
88
89
90
91
92
93
94
…
next ›
last »